Mario Fernández-Zertuche

Publication Activity (10 Years)

Years Active: 2018-2021
Publications (10 Years): 4

Top Topics

Molecular Docking

Cerebral Ischemia

Replacement Therapy

Top Venues

Molecules (Basel, Switzerland)

Basic & clinical pharmacology & toxicology

Chemical biology & drug design

Universidad Autónoma del Estado de Morelos Centro de Investigaciones Químicas

University of California Irvine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universidad Autónoma del Estado de Morelos Centro de Investigaciones Químicas Jan 24 1995

Mexico

Professor :: Chemistry Research Center

Syntex

Mexico

Group Leader :: Research Division

Education History

University of California Irvine Jun 19 1982

United States

PHD :: Chemisrtry

Publications

Ivan Ortega-Blake, Mario Fernández-Zertuche, Ignacio Regla, Walfred Sánchez-Peña, Antonieta Gómez-Solis, Paola Jaimes-Chavez, Arturo Galván-Hernández, Erika Tovar-Garduño, Lourdes Rodríguez-Fragoso
Preclinical safety evaluation of amphotericin A21: A novel antifungal. Basic & clinical pharmacology & toxicology 129 (1) (2021)
Zuleyma Martínez-Campos, Berto Tejera, Kayim Pineda-Urbina, Zeferino Gómez-Sandoval, Mario Fernández-Zertuche, Rodrigo Said Razo-Hernández
In silico structure-based design of GABAB receptor agonists using a combination of docking and QSAR. Chemical biology & drug design 94 (4) (2019)
Erika Tovar-Gudiño, Juan Alberto Guevara-Salazar, José Raúl Bahena-Herrera, José Guadalupe Trujillo-Ferrara, Zuleyma Martínez-Campos, Rodrigo Said Razo-Hernández, Ángel Santiago, Berto Tejera, Mario Fernández-Zertuche
Novel-Substituted Heterocyclic GABA Analogues. Enzymatic Activity against the GABA-AT Enzyme from Pseudomonas fluorescens and In Silico Molecular Modeling. Molecules (Basel, Switzerland) 23 (5) (2018)
Josué Rodríguez-Lozada, Erika Tovar-Gudiño, Juan Alberto Guevara-Salazar, Rodrigo Said Razo-Hernández, Ángel Santiago, Berto Tejera, Mario Fernández-Zertuche
QSAR and Molecular Docking Studies of the Inhibitory Activity of Novel Heterocyclic GABA Analogues over GABA-AT. Molecules (Basel, Switzerland) 23 (11) (2018)